September 27, 2020
September 27, 2020 – The U.S. FDA has approved a new indication for Fetroja® (cefiderocol),
manufactured by Shionogi. The drug is now indicated to treat patients 18 years
September 25, 2020
September 25, 2020 – The U.S. FDA has approved an expanded indication for Eraxis® (anidulafungin),
manufactured by Pfizer. The drug is now indicated to treat candidemia and
September 25, 2020
September 25, 2020 – The U.S. FDA has approved a new indication for Nucala® (mepolizumab),
manufactured by GlaxoSmithKline. Nucala is now indicated to treat patients who
September 23, 2020
September 23, 2020 –Sun Pharmaceuticals has issued a voluntary recall of one lot of Riomet ERTM
(metformin hydrochloride for extended-release oral suspension), 500mg/5mL
September 23, 2020
September 23, 2020 –The U.S. FDA is requiring an update to the black box warning – the agency’s most prominent safety warning on drug labels – for benzodiazepines. The warning describes
September 22, 2020
September 22, 2020 –Perrigo has voluntarily recalled all unexpired albuterol sulfate inhalation aerosol
manufactured by Catalent Pharma Solutions for Perrigo. The recall is due to possible
September 17, 2020
September 17, 2020 –Acella Pharmaceuticals has voluntarily recalled one lot of 15mg and one lot of 120mg NP Thyroid®, Thyroid Tablets, USP (levothyroxine and liothyronine) due
September 17, 2020
September 17, 2020 –The U.S. FDA has withdrawn approval for Belviq® (lorcaserin HCl) and Belviq XR®
(lorcaserin HCl extended release), manufactured by Eisai. Both drugs were indicated